Objective: Repeat median sternotomy is a potentially dangerous technique providing variable but mainly poor access to the mitral valve. Right thoracotomy is an alternative route previously used to access the mitral valve in the early years of cardiac surgery that offers the advantage of a fresh surgical field in the context of redo surgery. We have reviewed our experience with mitral prosthetic replacement undertaken via a right thoracotomy in order to determine the immediate and long-term results obtained with this approach. Methods: The operation was carried out on a beating heart using normothermic bypass without cross-clamping the aorta. Arterial inflow was achieved via the femoral artery or ascending aorta and venous drainage with bi-caval cannulae. Pre-, intra-and postoperative data were documented from case note review. Long-term follow-up was established from the UK Heart Valve Registry, referring Cardiologist, direct patient contact and the Scottish Registry for births and deaths. Statistical analysis was undertaken using a desktop computer package. Results: One hundred and twenty-five patients (mean age 63 years) underwent mitral prosthetic replacement by this technique. One hundred and eleven patients (86%) were in NYHA grades III or IV preoperatively. Twenty-two patients (16.6%) had also undergone previous CABG. Thirty-five patients (28%) had undergone two or more sternotomies. Mean bypass time was 83.6 min (SD 43.1). Postoperatively, mean duration of ventilation was 44 h; mean ITU stay was 4 days (SD 5.3) and mean inpatient total stay was 12 days. Thirty-six patients (28.8%) required inotropic support postoperatively. Complication rates were low: pleuro-pulmonary, 30 patients (24%), re-operation for bleeding, four patients (3.2%) and CVA, two patients (1.6%). Eight patients (6.4%) died within 30 days. Ten-year survival figures (Kaplan -Meier) were: 47% for all causes of mortality and 82.9% when only valve related causes of death were considered. Most of the patients (97.5%) had not required re-operation at 10 years. Conclusion: Mitral prosthetic replacement via a right thoracotomy on beating heart under normothermic bypass offers a safe alternative to redo median sternotomy in this high-risk group. Operative access is facilitated and procedural time reduced. Complication rates are low and perioperative mortality is lower than that generally reported with conventional surgery. q
Introduction
Revisional valve surgery has become increasingly frequent in the last four decades [1] reflecting the growing number of patients in whom valve prosthesis has been implanted. It has also been suggested that as time progresses, more patients requiring mitral valve repair or replacement [2, 3] will present with patent internal mammary artery or vein grafts. Revisional valve surgery is more complex than primary surgery and consequently is associated with higher mortality and morbidity [1] . There is some controversy regarding the degree of additional risk associated with repeat valve surgery. Although some authors deny any appreciable increase in risk [4 -6] , others have noted a significantly increased risk [7] for patients undergoing multiple procedures. Also, the evidence from US (Society of Thoracic Surgeons) and UK (Society of Cardiothoracic Surgeons) national databases would support the view that revisional mitral valve surgery carries a twofold to threefold increase in mortality.
A right lateral thoracotomy approach has been used previously in mitral valve surgery re-operations and has well-established benefits [2] . It has been suggested that this approach is time saving, safer for emergency procedures on thrombosed or acutely malfunctioning mitral valves [2] and helpful in situations where difficult dissection of the heart would be anticipated or patent internal mammary artery or saphenous vein grafts are present. In addition, surgery on this group of patients demands optimal myocardial protection and in theory, this is best achieved by maintenance of the coronary circulation during surgery.
Against this background, our technique for mitral prosthetic replacement through a right thoracotomy has been developed. The aims of the study are, therefore, to describe the technique, present the perioperative complications in this series of 125 patients and to discuss the possible benefits of the technique and their implications in an increasing population of mitral valve re-operations.
Materials and methods

Data acquisition
A retrospective case note review was performed on all patients undergoing right thoracotomy beating heart mitral prosthetic valve replacement between 1985 and 2001. The case notes were obtained for all patients. The factors analysed (Table 1) were selected as being relevant following a literature search of papers presenting revisional mitral valve surgery data. The survival status of all patients discharged from hospital was determined from the referring general practitioner and cardiologist, the UK heart valve registry [8] and the Scottish Registry for births and deaths.
Surgery
The indications for surgery were valve dysfunction due to degeneration, infection, thrombosis or mechanical failure. All procedures were undertaken through a right anterolateral thoracotomy using normothermic (378C) bypass at full-calculated flow. The heart was perfused as normal through the aortic root and allowed to beat. The heart was not fibrillated at any point in the procedure and neither aortic cross-clamping nor cardioplegia were used.
The right antero-lateral thoracotomy was created through the fifth inter-space. Arterial inflow was provided by cannulation of the ascending aorta (99 patients), right femoral artery (24 patients) or a combination of both vessels (two patients). Venous drainage was effected by caval cannulae inserted through purse string sutures placed in the fused pericardial and right atrial walls. The cannulae were advanced through the right atrium into the SVC and IVC. On full flow, a left atriotomy was made and a pump sucker used to rapidly empty the left atrium and cross the mitral valve if this was not already incompetent. Air embolism was avoided by keeping the left heart empty and vented to the atmosphere. Blood in the left ventricle was, therefore, preferentially expelled across the mitral valve because atmospheric pressure is much less than the aortic root pressure. Florid aortic incompetence is an obvious contraindication to this procedure. Minimal incompetence can be accepted although there is then the need for continued intra-cavity pump suction of the left ventricle during the surgery so that the valve can be adequately visualised. In general, we ran these cases with an on pump mean aortic pressure of 50-60 mmHg.
Data analysis
Data was entered into an Excel 5 spreadsheet database (Microsoft). Statistical analysis was carried out using a desktop computer package (Statview 5).
Results
Preoperative characteristics
One hundred and twenty-five patients (92 females, 73.6% and 33 males, 26.4%) were identified and studied. This represented 29.6% of all patients undergoing revisional mitral valve surgery in this period with the remaining 298 patients operated on through a conventional median sternotomy. The mean age was 63 years (range: 30 -80 years). Thirtynine had previously received a biological valve and 86 a mechanical valve. All patients had undergone at least one previous sternotomy. Thirty-two patients (25.6%) had two previous sternotomies and three patients had three previous sternotomies. In addition, 21 patients had undergone a previous left thoracotomy for closed mitral valvotomy and five patients had already had mitral valve surgery through the right chest. The majority of patients (111, 86%) were in either NYHA classes III or IV preoperatively. Most (106, 84.8%) presented either urgently i.e. during an acute admission to hospital with evidence of cardiac decompensation ðn ¼ 83Þ or as an acute emergency ðn ¼ 23Þ. The mean length of time since previous cardiac surgery was 7.7 years.
Perioperative findings
The duration of operation and cardiopulmonary bypass times is summarised in Table 2 . Nineteen patients had some coronary artery disease although only three required bypass grafts to the right coronary artery. Some degree of technical difficulty was encountered in ten patients (8%) who were found to have significant aortic incompetence, which had not been diagnosed on pre-operative investigation. This lead to significant reflux of blood into the operative field during surgery but could be managed with the use of vent suction.
Postoperative course
The mean postoperative blood loss was 581 ml (SD 426, range 120-2500). Patients stayed an average of 4 days (SD 5.3, range 0-36) in the cardiac ICU, with a further mean HDU stay of 10.6 days (SD 16.4). The overall hospital mean stay was 11.6 days (SD 18.9).
Postoperative complications occurred in 67 patients (53.6%). Pulmonary complications are summarised in Tables 3 and 4 and other complications in Table 4 . Re-opening for bleeding and/or a low cardiac output state was required in four patients and only two patients developed a cerebrovascular accident (1.6%). One of these was secondary to a major ventricular arrhythmia postoperatively.
Eight patients (6.4%) died within 30 days of surgery. Three died within hours of surgery from myocardial infarction, severe fixed pulmonary hypertension in combination with a low cardiac output and cardiogenic shock secondary to a severe protamine reaction, respectively. The remaining five patients died from a variety of causes: low cardiac output ðn ¼ 2Þ, septicaemia ðn ¼ 1Þ, respiratory failure (n ¼ 1) and acute renal failure in combination with bowel infarction ðn ¼ 1Þ.
Survival
Kaplan -Meier levels for 10-year survival are shown in Fig. 1 . Overall 10-year survival with all causes of mortality considered was 47%. Survival when only valve-associated causes of death were considered was 82%. Freedom from reoperation at 10 years was 97.5%.
Discussion
Excellent survival has been reported by other authors using the right thoracotomy approach [2, 4, 8, 9] . We believe that our beating heart technique offers further clinical advantages and is substantiated by the relatively large number of cases here reported. There is no survival data reported in the literature for re-operated mitral valve patients but our survival rate of 47% compares favourably with survival following first time mitral valve replacement (55% at 10 years: UK valve Registry). All non-randomised studies have the potential for selection bias but the right thoracotomy cases represented a significant proportion (29.6%) of our overall re-operative workload for mitral valve surgery. Thus, we believe that apart from satisfying the criteria for this approach, the procedure was made readily available to all suitable patients by those surgeons with an interest in this technique. We are currently conducting a further study comparing the outcomes of redo sternotomy and right thoracotomy for revisional mitral valve surgery. Normothermic perfusion reduces the risks of induced hypothermia including coagulopathy in a patient group susceptible to this complication. Our mean blood loss was 581 ml, which is less than our experience with for mitral valve re-operations through a median sternotomy when our mean blood loss is currently 843 ml. This is consistent with other published experience with the right thoracotomy approach for prosthetic mitral valve replacement. These have demonstrated decreased blood loss [10] and a 50% reduction in transfusion requirement compared with conventional redo-sternotomy [11] . Furthermore, it is known that limitation of pericardial dissection in combination with pharmacological manipulation of coagulation further minimises blood loss [1] . In our technique, there is no pericardial dissection. The low post-operative re-opening rate our series of 3.2% reflects the lack of haemorrhagic complications.
Our technique of operating on the beating heart via a right thoracotomy with normothermic perfusion differs from those described by Praeger [2] , Cohn [5] , Turina [11] and Tribble [9] . All used some degree of hypothermia and Pregar and Tribble also fibrillated the heart. Induced ventricular fibrillation [2, 9] avoids the need to cross-clamp the aorta and deliver cardioplegia, but may not provide optimal cardiac protection. Oxygen delivery to the left ventricle is markedly reduced and coronary flow re-distributed away from the sub-endocardium during electrically induced fibrillation [12] . We believe that allowing the myocardium to beat at normothermia with maintenance of normal coronary perfusion offers optimal myocardial protection with better preservation of myocardial blood flow distribution. This is of particular importance in patients with long-standing mitral valve disease who frequently have impaired ventricular function, a particular problem when such patients present in an emergency. We have experienced a relatively low inotropes support after revisional mitral valve surgery (28.8%). Considering the nature of patient population, low figure may reflect inherent advantage of maintaining continuous myocardial protection. It is also the case that the right thoracotomy approach avoids retraction compression of the right ventricle.
We have no data regarding transient neurological dysfunction and in a retrospective study of this nature such data would be difficult to obtain in a reliable manner. We, therefore, chose a 'hard' criterion i.e. CVA that we would also suggest is the issue of importance as transient dysfunction does not represent a long-term problem. The overall CVA rate in our series (1.6%) was remarkably low. This may relate in part to the avoidance of aortic crossclamping in elderly patients. It also clearly demonstrates that the operative technique offers a secure guarantee against air embolism. The most frequent post-operative complication was pulmonary infection, which occurred in 24% of cases. Tribble [9] suggested that pulmonary function might be more compromised than with a median sternotomy approach. This would be a logical consequence of the thoracotomy approach but, in our experience, the mean ventilation time of 44 h is no longer than that required following mitral valve re-operation through a sternotomy.
Conclusion
In our experience, revisional mitral prosthetic valve replacement undertaken through a right thoracotomy approach on a beating heart with normothermic perfusion has proved to be a safe, effective and reliable technique. Operative access is excellent. The perioperative mortality is relatively low at 6.4% and the CVA rate particularly encouraging at 1.6%. Blood loss would appear to be reduced also. We commend this technique as having general benefit in all revisional mitral valve surgery but there may be areas of particular benefit. Aortic cross-clamping is not necessary which is likely to be advantageous in elderly patients; difficult dissection is avoided which may be relevant where previous sternal infection has occurred and patent coronary grafts can be preserved. It is also likely that this technique may have further application in the field of minimal access mitral valve surgery. 
